Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and an accelerating…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and an accelerating…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and an accelerating…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and an accelerating…

November 21, 2025

Company Announcements

Evotec to Publish H1 2023 Results, Highlighting Strategic Impacts on the CDMO Sector

Evotec SE will release its first half-year 2023 earnings on August 29, 2023. This report will offer vital insights for contract development and manufacturing…

November 21, 2025

Company Announcements

Evotec–STORM Collaboration on STC-15: Implications for CDMO Partnerships

Evotec and STORM Therapeutics’ presentation of STC-15 at ACS Fall 2023 highlights CDMO collaboration trends, manufacturing demands, regulatory considerations, and outsourcing strategies.

November 21, 2025

Company Announcements

Symbiosis Marks 20 Years: A Milestone in CDMO Evolution

Symbiosis celebrates its 20th anniversary, reflecting on two decades of growth in the CDMO sector, technological innovation, regulatory alignment, and strategic partnerships shaping the…

November 21, 2025

Company Announcements

Evotec Adjusts 2023 Guidance After Cyber-Attack: Implications for CDMOs

Evotec has lowered its 2023 financial guidance after a cyber-attack disrupted operations, underscoring heightened cybersecurity and supply chain vulnerabilities in the CDMO sector.

November 20, 2025

Company Announcements

Steffen Helmling Joins Etherna as Chief Business Officer to Drive CDMO Expansion

Etherna appoints seasoned mRNA expert Steffen Helmling as Chief Business Officer to steer contract development and manufacturing growth across global CDMO operations.

November 20, 2025

Company Announcements

Mastering Project Coordination in CDMOs: Key Roles, Skills, and Impact on Pharma Manufacturing

Explore how a skilled Project Coordinator drives efficiency, compliance, and client satisfaction in contract development and manufacturing organizations (CDMOs).

November 20, 2025